Observational Study to Evaluate Health Status of Chronic Obstructive Pulmonary Disease (COPD) Patients in Response to Real-life Treatments in Thailand

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01169727

Enrollment

684

Registered

2010-07-26

Start date

2010-07-31

Completion date

2012-03-31

Last updated

2012-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

COPD and CCQ score, Changes in PEF,overall CCQ score

Brief summary

The purpose of this study is to evaluate health status of uncontrolled Chronic Obstructive Pulmonary Disease (COPD) patients in response to treatments in clinical practice.

Detailed description

MC MD

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

41 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Provision of informed consent prior to any study specific procedures 2. Male or non-pregnant female aged \>40 years 3. A clinical diagnosis of COPD with FEV1/ FVC \<0.70 and require combination or modified therapy 4. Smoke \> 10 Pack Year

Exclusion criteria

1. Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site) 2. Participation in a clinical study (precluding non-interventional study or registry) during the last 3 months

Design outcomes

Primary

Measure	Time frame
Changes in PEF and overall CCQ score	between the first visit and after 12 (plus or minus 1) weeks

Secondary

Measure	Time frame
Difference of the changes of PEF and overall CCQ score comparing between various treatments	between the first visit and after 12 (plus or minus 1) weeks

Countries

Thailand

Outcome results